Literature DB >> 12118106

Kupffer cell aggregation and perivenular distribution in steatohepatitis.

Jay H Lefkowitch1, Jennifer H Haythe, Nicole Regent.   

Abstract

Cytokine release from inflammatory cells, endotoxin, lipid peroxidation, and generation of reactive oxygen species are among the factors currently thought to be important in the pathogenesis of alcoholic and nonalcoholic steatohepatitis (SH). To more fully evaluate the role of mononuclear inflammatory cells in SH, 11 needle liver biopsies showing SH were selected for immunohistochemical staining to analyze the type and distribution of mononuclear inflammatory cells, including T and B lymphocytes and Kupffer cells (using immunostains for CD3, CD4, CD8; CD20; and CD68, respectively). An additional seven biopsies showing normal or fatty liver were also selected for CD68 immunostaining. Immunohistochemistry showed mild to moderate (1+ to 2+) numbers of T cells, with equal representation of CD4 and CD8 cells. T cells were found in portal tracts and in regions of SH. B cells were only rarely present. CD68 staining of simple fatty liver and normal liver showed elongated, spindle-shaped Kupffer cells diffusely distributed along the sinusoids throughout the lobules. In contrast, in cases of SH, there was prominent enlargement and aggregation of Kupffer cells in perivenular regions. Scattered large vacuoles of fat that had appeared to be within hepatocytes on routine stain were found actually to be within Kupffer cells. These results support the concept that hepatic Kupffer cells are a major immune effector cell in the pathogenesis of steatohepatitis. A potential direct Kupffer cell role in hepatic lipid processing is also postulated.

Entities:  

Mesh:

Year:  2002        PMID: 12118106     DOI: 10.1097/01.MP.0000019579.30842.96

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  26 in total

Review 1.  Update on fatty liver disease and steatohepatitis.

Authors:  Fatima Zahra Aly; David E Kleiner
Journal:  Adv Anat Pathol       Date:  2011-07       Impact factor: 3.875

Review 2.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?

Authors:  Nicolas Lanthier
Journal:  World J Hepatol       Date:  2015-09-08

Review 4.  Non-alcoholic fatty liver disease: an emerging pathological spectrum.

Authors:  Elie Serge Zafrani
Journal:  Virchows Arch       Date:  2003-12-18       Impact factor: 4.064

Review 5.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

Review 6.  Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages.

Authors:  Lucía Fuentes; Tamás Roszer; Mercedes Ricote
Journal:  Mediators Inflamm       Date:  2010-05-20       Impact factor: 4.711

7.  Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.

Authors:  Hiroko Itagaki; Kazuhiko Shimizu; Shunichi Morikawa; Kenji Ogawa; Taichi Ezaki
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

8.  Effects of different therapeutic methods and typical recipes of Chinese medicine on activation of c-Jun N-terminal kinase in kupffer cells of rats with fatty liver disease.

Authors:  Qin-He Yang; Si-Ping Hu; Yu-Pei Zhang; Huan-Huan Ping; Huan-Wen Yang; Tong-Yan Chen; Hai-Tao Liu
Journal:  Chin J Integr Med       Date:  2012-09-11       Impact factor: 1.978

Review 9.  Role of liver biopsy in nonalcoholic fatty liver disease.

Authors:  I L Ke Nalbantoglu; Elizabeth M Brunt
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 10.  Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Gregory Thomas Brown; David E Kleiner
Journal:  Metabolism       Date:  2015-12-02       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.